9/13/2026
Potential FDA approval of psychedelics impacts Japan
FDA approval of psychedelics like ibogaine could influence Japanese pharmacy practices.
Topic archive
psychedelics
10 stories
9/4/2026
Federal report urges states to prepare for psychedelics
States advised to anticipate FDA approval of psychedelics for medical use.
8/21/2026
University of Miami gifts ibogaine application to Trump admin
The move could expedite psychedelic research for veteran treatment.
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
8/14/2026
Veterans Affairs advances federal psychedelics push
New FDA guidance aligns with Veterans Affairs' psychedelics initiatives.
8/8/2026
SAMHSA gathers experts on psychedelics
AtaiBeckley and Compass Pathways explore new opportunities.
8/7/2026
Ibogaine gains traction among conservative leaders
Rick Perry and Bryan Hubbard lead efforts to legitimize ibogaine in Texas.
7/28/2026
Designing defensible protocols for psychedelics
Focus on documentation, training, and informed consent
7/17/2026
Ibogaine's long-term brain effects explored
Psychedelics like ibogaine may offer lasting brain changes.
7/15/2026
Royal Ontario Museum hosts psychedelics exhibit
Exhibit explores the evolving role of psychedelics in culture and medicine.